ESBF 19.30 Esb Financial Corp $ESBF Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ESBF 19.30 Esb Financial Corp $ESBF Hit a 52 week high of 19.30 Closing the day 09:30 at 19.30 +0.03 +0.16% With a day low of 19.30 and a total volume of 600.

ESBF Recent Posts: http://investorshangout.com/ESB-Financial-Corp-ESBF-54038/

ESBF Esb Financial Corp Recent Headline News

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of ESB Financial Corp. Regarding the Fairness of the Sale of the Company to WesBanco Inc. - ESBF
Business Wire - Wed Nov 05, 12:43PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of ESB Financial Corp. (NasdaqGS:ESBF) ("ESB" in connection with the sale of the Company to WesBanco Inc. (NasdaqGS:WSBC) ("WesBanco" .
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

ESB FINANCIAL CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Wed Nov 05, 12:41PM CST
Rigrodsky & Long, P.A.:
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

Lifshitz & Miller Law Firm Announces Investigation of American Realty Capital Properties Inc., Covance Inc., Elecsys Corporation, ESB Financial Corporation, Hudson Valley Holding Corp., Monarch Community Bancorp, Inc., and Penford Corporation
PR Newswire - Wed Nov 05, 12:22PM CST
American Realty Capital Properties Inc.
ESBF: 19.08 (-0.19), ESYS: 17.30 (-0.02), PENX: 18.80 (unch), HVB: 26.31 (-0.37), ARCP: 8.84 (+0.05), CVD: 100.75 (+0.02)

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Merger Of ESB Financial Corp. With WesBanco Inc. And Encourages Investors To Contact The Firm For Additional Information
Business Wire - Tue Nov 04, 5:21PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ESB Financial Corp. ("ESB" or the "Company" (Nasdaq: ESBF) relating to the proposed buyout of the Company by WesBanco Inc. ("WesBanco" .
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of ESB Financial Corp. of Investigation of the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to WesBanco Inc.
Business Wire - Mon Nov 03, 3:03PM CST
Levi & Korsinsky is investigating the Board of Directors of ESB Financial Corp. ("ESB" or "the Company" (NasdaqGS:ESBF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to WesBanco Inc. (NasdaqGS:WSBC).
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

Merger Arbitrage Mondays - November 3, 2014
Asif Suria - Seeking Alpha - Mon Nov 03, 12:35PM CST
Merger Activity increased last week with five new mergers announced. None of the pending deals closed last week. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. ...
ESBF: 19.08 (-0.19), AVIV: 33.45 (+0.25), ACMP: 62.12 (+0.38), CPWR: 10.17 (-0.02), WSBC: 35.31 (-0.30), CQB: 14.45 (+0.01), OHI: 38.05 (+0.26), TRNX: 26.24 (+0.13), WMGIZ: 4.40 (-0.03), COVS: 2.79 (unch), WPZ: 51.58 (+0.40)

Harwood Feffer LLP Announces Investigation of ESB Financial Corp.
PR Newswire - Fri Oct 31, 6:50PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of ESB Financial Corp. ("ESB Financial" or the "Company" (NASDAQ: ESBF) concerning the proposed acquisition of the Company by WesBanco Inc. ("WesBanco" .
ESBF: 19.08 (-0.19)

ESB FINANCIAL CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ESB Financial Corp. (ESBF) Over the Proposed Sale of the Company to WesBanco, Inc.
PR Newswire - Fri Oct 31, 6:20PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ESB Financial Corp. ("ESB" or the "Company" (Nasdaq: ESBF) for potential breaches of fiduciary duties in connection with the sale of the Company to WesBanco, Inc. ("WesBanco" (WSBC) for approximately $324.40 million. The Company's stockholders will receive .502 shares of WesBanco and $1.76 for each share of ESB common stock they own.
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of ESB Financial Corp. in Connection with the Sale of the Company
Business Wire - Fri Oct 31, 5:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ESB Financial Corp. ("ESB Financial" or the "Company" (Nasdaq: ESBF) relating to the proposed acquisition by WesBanco Inc. ("WesBanco" .
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

ESB FINANCIAL SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to WesBanco
Business Wire - Fri Oct 31, 10:43AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of ESB Financial Corp. ("ESB" (NasdaqGS: ESBF) concerning the sale to WesBanco. Under the terms of the transaction, ESB shareholders will only receive 0.502 shares of WesBanco and $1.76 in cash per ESB share owned. The total consideration gives ESB a value of approximately $17.65 per share.
ESBF: 19.08 (-0.19)

ESBF INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of ESB Financial Corp. Regarding the Fairness of the Sale of the Company to WesBanco Inc. -- ESBF
PR Newswire - Fri Oct 31, 10:09AM CDT
Levi & Korsinsky is investigating the Board of Directors of ESB Financial Corp. ("ESB" or "the Company" (NasdaqGS: ESBF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to WesBanco Inc. (NasdaqGS: WSBC).
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

Nasdaq stocks posting largest volume increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ESBF: 19.08 (-0.19), CRNT: 1.17 (+0.02), RDCM: 9.08 (-0.22), MCGC: 3.68 (unch), BBSI: 22.45 (-0.34), INGN: 25.11 (-1.01), CDTI: 2.24 (-0.07), ATTU: 9.00 (-0.16), HOTR: 1.92 (-0.04), ARCP: 8.84 (+0.05), SMBC: 37.50 (+0.49), XOOM: 14.64 (-0.30)

Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 33.90 (+3.23), ABMD: 33.37 (-0.23), BGFV: 13.23 (-0.15), RDCM: 9.08 (-0.22), AMED: 25.52 (+0.41), MRCY: 13.50 (-0.13), OMER: 19.12 (-0.59), ESBF: 19.08 (-0.19), EVOK: 6.55 (+0.25), IQNT: 19.06 (+0.44), KONA: 22.92 (-0.09), TQNT: 22.25 (+0.15), LAKE: 11.86 (-0.38), SAJA: 6.21 (+0.31)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of ESB Financial Corp. in Connection with the Sale of the Company -ESBF
PR Newswire - Thu Oct 30, 3:50PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ESB Financial Corp. ("ESB Financial" or the "Company" (Nasdaq -ESBF-News) relating to the proposed acquisition by WesBanco Inc. ("WesBanco" .
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of ESB Financial Corp. Regarding the Fairness of the Sale of the Company to WesBanco Inc.
Business Wire - Thu Oct 30, 2:10PM CDT
Levi & Korsinsky is investigating the Board of Directors of ESB Financial Corp. ("ESB" or "the Company" (NasdaqGS:ESBF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to WesBanco Inc. (NasdaqGS:WSBC).
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of ESB Financial Corp. Concerning its Proposed Sale to WesBanco Inc. - ESBF
Business Wire - Thu Oct 30, 12:21PM CDT
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of ESB Financial Corp. (NASDAQ: ESBF) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop ESB Financial to maximize shareholder value before agreeing to be acquired by WesBanco Inc. (NASDAQ: WSBC).
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:47AM CDT

ABMD: 33.37 (-0.23), CALX: 10.90 (-0.17), LOJN: 2.65 (-0.03), ALU: 3.06 (-0.12), CDTI: 2.24 (-0.07), NKA: 4.99 (+0.11), ARAY: 7.03 (-0.02), GLUU: 3.61 (-0.09), PDII: 1.91 (-0.04), OMER: 19.12 (-0.59), ESBF: 19.08 (-0.19), CRNT: 1.17 (+0.02), CBDE: 0.82 (-0.02), PRXL: 56.48 (+0.28), BWEN: 6.67 (+0.02), ALDX: 7.52 (+0.01), BBSI: 22.45 (-0.34), LAKE: 11.86 (-0.38), OPHC: 1.00 (+0.06), WTW: 27.54 (+0.78)

WesBanco, Inc. Furthers Expansion into Pittsburgh Market; Announces Agreement and Plan of Merger with ESB Financial Corporation
Business Wire - Wed Oct 29, 4:09PM CDT
WesBanco, Inc. ("WesBanco" (Nasdaq:WSBC) and ESB Financial Corporation ("ESB" (Nasdaq:ESBF) jointly announced today that they have executed a definitive Agreement and Plan of Merger providing for the merger of ESB with and into WesBanco. James C. Gardill, Chairman of the Board, and Todd F. Clossin, President & CEO, of WesBanco and William B. Salsgiver, Chairman of the Board, and Charlotte A. Zuschlag, President & CEO, of ESB, made the joint announcement.
ESBF: 19.08 (-0.19), WSBC: 35.31 (-0.30)

ESB Financial Corp. (ESBF) Stock Research Links

ESBF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Updated Category News Views 101

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 37

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 25

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Updated Category News Views 47

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
Beta Bionics Faces Securities Fraud Class Action Challenges

Updated Category News Views 65

The Unexpected Slide of Beta Bionics So your wallet took a bruising with this Beta Bionics deal, eh? It’s another one of those wild tales from the stock jungle where everyone watching the NASDAQ:BBNX action got clipped when reality didn't match the company chest-thumping. Glancy Prongay Wolke & Rotter LLP just laid it out—ripping the Band-Aid off what Beta Bionics...

Continue Reading
Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 35

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Regal Healthcare: Five Years of Founder-Friendly Valor

Updated Category News Views 43

Why Founder-Friendly Matters More Than Ever in Healthcare Well folks, in a year when everyone's tossing around terms like 'value-added' and 'strategic support', seeing Regal Healthcare Capital Partners snag slot number five straight on Inc.'s Founder-Friendly Investors list feels like catching a rare breed of fish twice. Seriously, these folks are stamping their forte as...

Continue Reading
2021 Ferrari Portofino Shines Bright at Jake's Motorcars

Updated Category News Views 76

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 15

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading

Top 5 Most Recently Viewed Articles

Truist Adjusts Price Target for Edwards Lifesciences Stocks

Updated Category News Views 198

Truist Adjusts Price Target for Edwards Lifesciences Stocks Recently, Truist Securities made a significant alteration to the price target for Edwards Lifesciences (NYSE: EW), which is a key player in the medical device industry. They have reduced the target from $71.00 to $70.00, while maintaining a Hold rating on the stock. This decision was influenced by the company's...

Continue Reading
Exor N.V. Updates on Recent Share Buyback Activities

Updated Category News Views 137

Periodic Update on Exor N.V.'s Share Buyback Program Exor N.V. (AMS: EXO) has made significant strides in its ongoing share buyback initiative, demonstrating its commitment to enhancing shareholder value. Recently, the company announced substantial transactions under its second tranche of the buyback program, allocating up to €125 million to repurchase shares. These...

Continue Reading
Gillon Property Group Launches Comprehensive Real Estate Firm

Updated Category News Views 514

Introduction to Gillon Property Group's New Venture Gillon Property Group (GPG) has officially launched a fresh, all-encompassing real estate enterprise aimed at reshaping the landscape of commercial real estate investment, development, and operations. Centered on their mission of crafting vital spaces that enhance community engagement, GPG aims to set new standards in...

Continue Reading
HP Inc. Sees Growth in Revenue and Earnings for Q3 2025

Updated Category News Views 258

HP Inc. Sees Growth in Revenue and Earnings for Q3 2025 HP Inc. has recently shared its financial results for the third quarter of fiscal 2025, and there's plenty to unpack. With a notable increase in both revenue and earnings, the company is clearly on a positive trajectory. Financial Performance Overview In the third quarter, HP Inc. reported a GAAP diluted earnings per...

Continue Reading
Join the Exciting HTX Trading Championship for Big Prizes

Updated Category News Views 149

HTX Trading Championship: Unleash Your Trading Potential As market dynamics shift dramatically and opportunities arise, HTX invites traders from around the globe to engage in its most thrilling event yet—the Trading Championship. This much-anticipated contest, featuring a staggering prize pool exceeding $1 million, showcases a blend of talent, strategy, and competition...

Continue Reading